Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martín de Santibañes has a total of 265 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-term graft and patient survival of patients with portal vein stenosis after pediatric liver transplantation: Results from the multicenter multinational PORTAL registry

    by Bader A. Alfares, Lydia Sieben, Piotr Kaliciński, Malgorzata Markiewicz-Kijewska, Adam Koleśnik, Guillermo Cervio, Julia Minetto, Sergio Sierre, Stéphanie Franchi-Abella, Emmanuel Gonzales, et al.

    Pediatric liver transplantation (pLT) has become a standard treatment, but it is still burdened by complications such as portal vein stenosis (PVS). PVS can result in compromised graft function and portal hypertension if left untreated. We aimed to assess long-term patient and graft survival after PVS diagnosis following pLT. Our study analyzed data from the Portal Vein Obstruction Revascularisation Therapy After Liver Transplantation (PORTAL) registry, which contains retrospective data from 21 centers across 18 countries, over a 20-year period. Graft and patient survival rates were determined after PVS diagnosis. This study included 239 patients (53% female; median age at pLT 1.1   y) diagnosed with PVS. The median age at diagnosis was 2.7 years. The overall 10-year graft survival was 90%, and the 10-year patient survival was 96%. One-year graft and patient survival were lowest in patients with PVS diagnosed ≤7 days after pLT (80% and 92%, respectively). Initial treatment strategies comprised mostly endovascular procedures (87%), followed by conservative (11%) and surgical treatment (3%). Patient outcomes did not differ between these treatment groups. Within the endovascular group, graft survival in patients treated with stent (n=26) was significantly lower compared with those with percutaneous transluminal angioplasty (n=181) (88% vs. 98%, respectively, p =0.01). Our findings indicate excellent graft and patient survival after PVS diagnosis and its treatment. Further research is needed to determine the safety and efficacy of optimal management strategies, especially in early-onset PVS.

  • Surgical resection of inferior vena cava leiomyosarcoma: a multidisciplinary approach and therapeutic insights

    by Vadim Kotowicz, Tomás D'ANgelo, Nicolás Feijóo, Germán Fortunato, Martín De Santibañes

    Leiomyosarcomas (LMS) are rare tumors originating in smooth muscle cells, constituting 5-7% of soft tissue sarcomas. They primarily affect the inferior vena cava (IVC) and have a grim prognosis. Standard treatment is complete surgical resection (R0), which varies by tumor location. We present a female patient with IVC LMS in zone II who underwent complete en bloc tumor resection without any posterior reconstruction. No complications were notified. Complete R0 surgical resection, involving tumor mass and right kidney en bloc removal, with left renal vein ligation without reconstruction, is safe in cases with sufficient collateral venous drainage, avoiding graft reconstruction complications.

  • Resección quirúrgica del leiomiosarcoma de la vena cava inferior: abordaje multidisciplinario y aspectos terapéuticos

    by Vadim Kotowicz, Tomás D'ANgelo, Nicolás Feijóo, Germán Fortunato, Martín De Santibañes

    Los leiomiosarcomas (LMS) son tumores raros originados en las células del músculo liso, y constituyen el 5-7% de los sarcomas de tejido blando. Afectan principalmente a la vena cava inferior (VCI) y tienen un pronóstico sombrío. El tratamiento estándar es la resección quirúrgica completa (R0), que varía según la ubicación del tumor. Presentamos el caso de una paciente de sexo femenino con LMS en la VCI en la zona II, a quien se le realizó una resección completa en bloque del tumor sin ninguna reconstrucción posterior. No se notificaron complicaciones. La R0, que incluye la masa tumoral y la extirpación en bloque del riñón derecho, con ligadura de la vena renal izquierda sin reconstrucción, es segura en casos con drenaje venoso colateral suficiente, y evita las complicaciones de la reconstrucción con injertos.

  • Top Cited Papers
    Open Access

    Toward a Standardization of Learning Curve Assessment in Minimally Invasive Liver Surgery

    by Christoph Kuemmerli, Johannes M.A. Toti, Fabian Haak, Adrian T. Billeter, Felix Md Nickel, Cristiano Guidetti, Martin Santibanes, Luca Vigano, Joël L. Lavanchy, Otto Kollmar, et al.

    Objective: The aim was to analyze the learning curves of minimal invasive liver surgery(MILS) and propose a standardized reporting. Summary Background Data: MILS offers benefits compared to open resections. For a safe introduction along the learning curve, formal training is recommended. However, definitions of learning curves and methods to assess it lack standardization. Methods: A systematic review of PubMed, Web of Science, and CENTRAL databases identified studies on learning curves in MILS. The primary outcome was the number needed to overcome the learning curve. Secondary outcomes included endpoints defining learning curves, and characterization of different learning phases(competency, proficiency and mastery). Results: 60 articles with 12’241 patients and 102 learning curve analyses were included. The laparoscopic and robotic approach was evaluated in 71 and 18 analyses and both approaches combined in 13 analyses. Sixty-one analyses (60%) based the learning curve on statistical calculations. The most often used parameters to define learning curves were operative time (n=64), blood loss (n=54), conversion (n=42) and postoperative complications (n=38). Overall competency, proficiency and mastery were reached after 34 (IQR 19-56), 50 (IQR 24-74), 58 (IQR 24-100) procedures respectively. Intraoperative parameters improved earlier (operative time: competency to proficiency to mastery: −13%, 2%; blood loss: competency to proficiency to mastery: –33%, 0%; conversion rate (competency to proficiency to mastery; −21%, −29%), whereas postoperative complications improved later (competency to proficiency to mastery: −25%, −41%). Conclusions: This review summarizes the highest evidence on learning curves in MILS taking into account different definitions and confounding factors. A standardized three-phase reporting of learning phases (competency, proficiency, mastery) is proposed and should be followed.


  • Surgical strategies to treat portal vein thrombosis during adult liver transplantation

    by Martin de Santibanes, Victoria Ardiles, Jimmy Walker Uño, Juan Mattera, Eduardo de Santibanes, Juan Pekolj

    Background The incidence of portal vein thrombosis (PVT) at the time of liver transplantation (LT) may be variable and underestimated. Therefore, preoperative diagnosis and stratification of its extension is so relevant for adequate surgical planning. Revascularization of the portal vein graft becomes essential for graft and patient survival after LT. Early stages of PVT may be managed with eversion thrombectomy and end-to-end anastomoses. However, severe PVT (grades 3 and 4) poses significant challenges for patients requiring LT, resulting in more complex surgeries and higher complication rates. To address these complexities, various surgical techniques have been developed, including collateral alternative vessel utilization, renoportal anastomoses, mesoportal jump graft placement, cavoportal hemitranspositions, portal vein arterialization, or even multivisceral transplantation. Purpose We herein describe the preoperative surgical planning as well as the different surgical strategies possible to treat portal vein thrombosis during LT. Conclusion A comprehensive preoperative evaluation of PVT is crucial for accurately assessing its extent and severity. This information is vital for proper surgical planning, which ultimately prepares both the surgeon and the patient for potentially complex procedures during LT. The surgical alternatives presented in this technical report offer promising solutions for treating PVT during LT, making it a viable option for selected patients.


  • Open Access

    Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?

    by Francisco Calderon Novoa, Victoria Ardiles, Eduardo de Santibañes, Juan Pekolj, Jeremias Goransky, Oscar Mazza, Rodrigo Sánchez Claria, Martín de Santibañes

    Colorectal cancer is the third most common cancer worldwide, and up to 50% of all patients diagnosed will develop metastatic disease. Management of colorectal liver metastases (CRLM) has been constantly improving, aided by newer and more effective chemotherapy agents and the use of multidisciplinary teams. However, the only curative treatment remains surgical resection of the CRLM. Although survival for surgically resected patients has shown modest improvement, this is mostly because of the fact that what is constantly evolving is the indication for resection. Surgeons are constantly pushing the limits of what is considered resectable or not, thus enhancing and enlarging the pool of patients who can be potentially benefited and even cured with aggressive surgical procedures. There are a variety of procedures that have been developed, which range from procedures to stimulate hepatic growth, such as portal vein embolization, two-staged hepatectomy, or the association of both, to technically challenging procedures such as simultaneous approaches for synchronous metastasis, ex-vivo or in-situ perfusion with total vascular exclusion, or even liver transplant. This article reviewed the major breakthroughs in liver surgery for CRLM, showing how much has changed and what has been achieved in the field of CRLM.


  • Open Access

    Technical Implications for Surgical Resection in Locally Advanced Pancreatic Cancer

    by Martín de Santibañes, Juan Pekolj, Rodrigo Sanchez Claria, Eduardo de Santibañes, Oscar Maria Mazza

    Pancreatic ductal adenocarcinoma remains a global health challenge and is predicted to soon become the second leading cause of cancer death in developed countries. Currently, surgical resection in combination with systemic chemotherapy offers the only chance of cure or long-term survival. However, only 20% of cases are diagnosed with anatomically resectable disease. Neoadjuvant treatment followed by highly complex surgical procedures has been studied over the last decade with promising short- and long-term results in patients with locally advanced pancreatic ductal adenocarcinoma (LAPC). In recent years, a wide variety of complex surgical techniques that involve extended pancreatectomies, including portomesenteric venous resection, arterial resection, or multi-organ resection, have emerged to optimize local control of the disease and improve postoperative outcomes. Although there are multiple surgical techniques described in the literature to improve outcomes in LAPC, the comprehensive view of these strategies remains underdeveloped. We aim to describe the preoperative surgical planning as well different surgical resections strategies in LAPC after neoadjuvant treatment in an integrated way for selected patients with no other potentially curative option other than surgery.


  • Assessment of Vascular Structures in BDI’s

    by David Alberto Biagiola, Martín de Santibañes

  • Anatomical Considerations

    by Martín de Santibañes, Eduardo de Santibañes